Lifeboat Foundation

Small study is ‘not rock solid’ but could have huge consequences for ageing, experts say.

A small clinical trial, which was conducted by a team of researchers led by Dr. Greg Fahy, has shown for the first time in humans that reversing biological age may be possible.

The results of TRIIM are in

The researchers spent a year running the Thymus Regeneration, Immunorestoration, and Insulin Mitigation (TRIIM) trial, which included 9 volunteers aged between 51 and 65. The trial was aimed at testing if a growth hormone and drug combination could be used safely in humans to restore thymic function lost due to aging [1].

Our mission is to promote the advancement of biomedical technologies which will increase healthy human lifespan.

A 5 year study. In recent years it has been shown to extend the lives of nematodes (or roundworms) by 57% and mice by 6%. In humans, claims abound that metformin-takers are living longer, having fewer cardiovascular episodes and seeing reduced odds of getting cancer.

Groundbreaking TAME trial, which directly targets aging as an endpoint, finally begins this November, reveals lead clinician Dr Nir Barzilai.

NBC is developing an untitled cryonics-themed project which hails from writer and executive producer David Slack and filmmaker Phillip Noyce who will direct the pilot and executive produce.

Sony Television produces the series which follows an enigmatic billionaire who has gathered more than 250 people who attempt to cheat death by undergoing cryogenic suspension in hopes that a future breakthrough would someday allow them to be brought back to life.

However, as these people from different moments in time wake up, they soon realise you can’t cheat death without paying a price. Josh Berman and Chris King will also serve as executive producer. Noyce also helmed the pilots of and executive produced ABC’s “Revenge” and FOX’s “The Resident”.

Click on photo to start video.

They’re insidious. They’re lethal, and they’re here to take your life. They’re the hallmarks of aging!

AgeX CEO Dr. Michael West discusses the technology behind cell aging reversal described in the publication “Toward a Unified Theory of Aging and Regeneration.”

A joint study by researchers at the National Institutes of Health (NIH) and the University of Maryland (UMD) has revealed a previously undocumented protective function of the telomerase enzyme.

Telomerase is used by somatic cells too

It was thought for a long time that telomerase is only active in certain cell types, such as stem cells, immune cells, and embryonic cells, in order to protect them from aging. Aside from a few cell types and, of course, cancer cells, which are able to hijack the telomerase enzyme in order to replicate uncontrollably, researchers believed that the enzyme is switched off in other types of cells.